• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周血小板计数与肝萎缩相关,并可预测肝移植等待名单上的长期死亡率。

Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list.

机构信息

Liver Center, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA.

出版信息

Transpl Int. 2013 Apr;26(4):435-42. doi: 10.1111/tri.12064. Epub 2013 Jan 29.

DOI:10.1111/tri.12064
PMID:23356587
Abstract

Several studies have shown a direct role of liver atrophy in the pathogenesis of thrombocytopenia of cirrhosis via reduced production of thrombopoeitin. About 181 patients listed for liver transplantation at a single transplant center were evaluated at the time of listing with laboratory tests and volumetric liver measurements using computed tomography. Expected normal liver volume was calculated using the Heinemann formula. Liver volume ratio (LVR) was calculated as actual liver volume over expected liver volume. Patients were predominantly male (70.7%), with viral hepatitis (60.2%), had a mean age of 51.8 years (SD 8.7), model for end stage liver disease (MELD) of 14 (SD 6.4), LVR of 0.95 (SD 0.3), and platelet count of 105,000/mcL (SD 66,000). Platelet count (P < 0.0001) correlated more strongly with LVR than MELD, MELD components (P = 0.27) or serum albumin (P = 0.003). Platelet count (HR 0.987, 95% CI 0.979-0.994, P = 0.001) was a strong independent predictor of mortality. Patients with platelet count < 100,000/mcL had a shorter survival (935 vs. 1396 days, P = 0.002) and higher death rate (42.2% vs. 23.6%, P = 0.01), but no different transplantation rate (36.7% vs. 33.3%, P = 0.64) compared to those with platelet count ≥ 100,000/mcL. Low platelet count corresponds to higher waiting list mortality and is a sign of advanced liver atrophy.

摘要

几项研究表明,通过减少血小板生成素的产生,肝萎缩在肝硬化血小板减少症的发病机制中起着直接作用。在单一移植中心,对 181 名等待肝移植的患者进行了评估,评估时进行了实验室检查和使用计算机断层扫描进行容积肝脏测量。使用 Heinemann 公式计算预期正常肝体积。肝体积比 (LVR) 计算为实际肝体积与预期肝体积之比。患者主要为男性 (70.7%),病毒性肝炎 (60.2%),平均年龄为 51.8 岁 (标准差 8.7),终末期肝病模型 (MELD) 为 14 (标准差 6.4),LVR 为 0.95 (标准差 0.3),血小板计数为 105,000/mcL(标准差 66,000)。血小板计数 (P < 0.0001) 与 LVR 的相关性强于 MELD、MELD 成分 (P = 0.27) 或血清白蛋白 (P = 0.003)。血小板计数 (HR 0.987,95%CI 0.979-0.994,P = 0.001) 是死亡率的独立强预测因素。血小板计数 < 100,000/mcL 的患者存活率更短 (935 天与 1396 天,P = 0.002),死亡率更高 (42.2%与 23.6%,P = 0.01),但与血小板计数≥100,000/mcL 的患者相比,移植率无差异 (36.7%与 33.3%,P = 0.64)。血小板计数低对应较高的等待名单死亡率,是肝萎缩严重的标志。

相似文献

1
Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list.外周血小板计数与肝萎缩相关,并可预测肝移植等待名单上的长期死亡率。
Transpl Int. 2013 Apr;26(4):435-42. doi: 10.1111/tri.12064. Epub 2013 Jan 29.
2
Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.终末期肝病模型和终末期肝病-钠评分可预测等待肝移植前及等待肝移植期间的死亡率。
Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.
3
Serum sodium predicts mortality in patients listed for liver transplantation.血清钠可预测列入肝移植名单患者的死亡率。
Hepatology. 2005 Jan;41(1):32-9. doi: 10.1002/hep.20517.
4
Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?终末期肝病模型(MELD)评分是否不仅足以预测等待名单上的死亡,还能预测移植后的生存率?
Transpl Int. 2006 Apr;19(4):275-81. doi: 10.1111/j.1432-2277.2006.00250.x.
5
Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.巴西圣保罗的肝脏分配测试:终末期肝病模型实施与等待名单死亡率降低之间的关系。
Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.
6
Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.农村地区肝移植候选者死亡率的临床流行病学分析。
Transpl Int. 2011 Mar;24(3):292-9. doi: 10.1111/j.1432-2277.2010.01200.x. Epub 2010 Dec 10.
7
Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation.低钠血症是肝硬化患者接受肝移植的早期死亡的一个有价值的预测指标。
Clin Transplant. 2011 Jul-Aug;25(4):638-45. doi: 10.1111/j.1399-0012.2010.01350.x. Epub 2010 Nov 16.
8
Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.肝移植等待名单中终末期肝病模型(MELD)评分分析
Transplant Proc. 2007 Oct;39(8):2511-3. doi: 10.1016/j.transproceed.2007.07.023.
9
Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.MELD 评分的动态变化不仅可以预测等待移植期间的存活率,还可以预测肝移植后的总体存活率。
Transpl Int. 2012 Sep;25(9):935-40. doi: 10.1111/j.1432-2277.2012.01519.x. Epub 2012 Jul 9.
10
Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year.如果等待时间超过1年,胆红素似乎是影响肝移植等待名单上死亡率的唯一独立变量。
Transplant Proc. 2005 Dec;37(10):4365-6. doi: 10.1016/j.transproceed.2005.11.015.

引用本文的文献

1
Hematological Abnormalities in Cirrhosis: A Narrative Review.肝硬化中的血液学异常:一篇叙述性综述。
Cureus. 2023 May 19;15(5):e39239. doi: 10.7759/cureus.39239. eCollection 2023 May.
2
A case report of a pregnant woman with compensated liver cirrhosis and pancytopenia.一名患有代偿期肝硬化和全血细胞减少症的孕妇的病例报告。
Clin Case Rep. 2023 Jun 13;11(6):e7500. doi: 10.1002/ccr3.7500. eCollection 2023 Jun.
3
Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study.
重组人血小板生成素治疗慢性肝病相关性血小板减少症患者行侵入性操作:一项回顾性研究。
World J Gastrointest Surg. 2022 Nov 27;14(11):1260-1271. doi: 10.4240/wjgs.v14.i11.1260.
4
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures.中欧肝病协作组(CEHC)关于血小板生成素受体激动剂在接受侵入性操作的慢性肝病患者中应用的实践指南。
J Clin Med. 2021 Nov 19;10(22):5419. doi: 10.3390/jcm10225419.
5
Clinical Implications of Thrombocytopenia for the Cirrhotic Patient.血小板减少症对肝硬化患者的临床意义
Hepat Med. 2020 Apr 14;12:49-60. doi: 10.2147/HMER.S244596. eCollection 2020.
6
Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options.肝硬化中的血小板减少症:病理生理学与管理选择综述
Clin Liver Dis (Hoboken). 2019 Dec 20;14(5):183-186. doi: 10.1002/cld.860. eCollection 2019 Nov.
7
Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.肝硬化患者的未成熟血小板分数和血小板生成素:一项队列研究。
PLoS One. 2018 Feb 13;13(2):e0192271. doi: 10.1371/journal.pone.0192271. eCollection 2018.
8
Splenectomy before adult liver transplantation: a retrospective study.成人肝移植前脾切除术:一项回顾性研究。
BMC Surg. 2017 Apr 20;17(1):44. doi: 10.1186/s12893-017-0243-9.
9
Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation.等待肝移植名单上的肝细胞癌患者的桥接和降期治疗
Transl Gastroenterol Hepatol. 2016 Apr 14;1:34. doi: 10.21037/tgh.2016.03.04. eCollection 2016.
10
Hemophilia Liver Transplantation Observational Study.血友病肝移植观察性研究。
Liver Transpl. 2017 Jun;23(6):762-768. doi: 10.1002/lt.24688.